Trial | NCT00373776  Report issue

Title

Miltefosine for Mucosal Leishmaniasis

  • Phase

    Phase 1/Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    miltefosine ...

  • Study Participants

    75
This trial will study miltefosine as a treatment for mucosal leishmaniasis.
Treat bolivian mucosal leishmaniasis with miltefosine.
Study Started
Apr 30
2004
Study Completion
May 31
2006
Last Update
Sep 08
2006
Estimate

Drug miltefosine 2.5 mg/kg/day for 28 days

Criteria 

Inclusion Criteria:

Mucosal leishmaniasis

Exclusion Criteria:

Abnormal liver function tests (LFT)
Abnormal kidney function test
Concomitant diseases
No Results Posted